Boulder’s InDevR raises $7M
BOULDER — InDevR Inc., a Boulder-based firm that makes analytical technology for the life sciences industry, recently completed a $7 million Series A funding round led by Adjuvant Capital.
The financing will support research and development and expand commercialization of InDevR’s VaxArray influenza vaccine potency testing system, according to a company news release.
“Our partnership with Adjuvant represents the next phase of company growth for us, and we are looking forward to furthering the positive impact on global health that new technologies such as VaxArray can have through process improvements and cost reduction,” InDevR…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Boulder-based publishing technology company Sovrn Holdings Inc. has named Will Duckworth its chief technology officer.
-
A Boulder fiber infrastructure company and broadband internet provider said it has raised $80 million…
-
Knowledge Factor Inc., a software-as-a-service company that provides cognitive science-based assessment, training and data analytics…
-
Tilled Inc., a Boulder payment-facilitation technology company, recently completed a $12.5 million investment round, bringing…
